Vaccines, blood, antisera, toxins and cultures in   Guyana

Exports In 2022, Guyana exported $2.34M in Vaccines, blood, antisera, toxins and cultures, making it the 92nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 43rd most exported product in Guyana. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Guyana are: Switzerland ($2.23M), Barbados ($96k), Jamaica ($7.44k), China ($2.4k), and Grenada ($1.76k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Guyana between 2021 and 2022 were Switzerland ($2.23M), Jamaica ($7.44k), and China ($2.4k).

Imports In 2022, Guyana imported $9.85M in Vaccines, blood, antisera, toxins and cultures, becoming the 163rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 79th most imported product in Guyana. Guyana imports Vaccines, blood, antisera, toxins and cultures primarily from: South Korea ($1.46M), Kenya ($1.35M), India ($1.18M), United States ($921k), and United Arab Emirates ($844k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Guyana between 2021 and 2022 were South Korea ($973k), Sweden ($550k), and Spain ($500k).